Bionomics Limited is a biotechnology company focused on developing innovative therapeutic solutions for various neurological and psychiatric disorders. The company leverages its proprietary drug discovery platform to identify and advance novel compounds that can address unmet medical needs in areas such as anxiety, depression, and cognitive dysfunction. With a strong commitment to research and development, Bionomics collaborates with academic institutions and industry partners to bring new treatments to clinical trials, aiming to improve the quality of life for patients facing challenging mental health conditions. Read More
Trump Media (NASDAQ: DJT) saw a sharp spike on Election Day as traders speculated that a second Trump presidency could boost business. Often viewed as a proxy for Trump’s White House chances, DJT attracted heavy retail interest, particularly on WallStreetBets, where GameStop (NYSE: GME) was introduced and gained momentum. This rally could set the stage for other micro-cap stocks highlighted here.
Bionomics shares are trading higher by 104% Tuesday morning. The company announced a AUD$1 million milestone payment from Carina Biotech for their oncology program.
